Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Samaritan Presented Favorable Caprospinol Data at Alzheimer's Drug Development Summit
In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals
Princeton Premier Honors Mr. Han de Min with Inclusion in the 2007-2008 Princeton Premier Registry
Princeton Premier Honors Mr. Han de Min With Inclusion in the 2007-2008 Princeton Premier Registry. Han is currently serving as a vice president for Aspen Technology and has been doing so for over a year. He currently acts as a consultant on strategic business planning. Han is a respected member... - November 27, 2007 - Princeton Premier
Thomas Waldmann, Chief, NCI to Give Keynote Talk at Immunodiagnostics & Immunomonitoring Conference
Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentation at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007 - November 22, 2007 - GTCbio
OptimizeRx Helps Patients Save on Rising Prescription Costs
Tens of thousands of patients have visited the OPTIMIZERx website (www.optimizerx.com) to save on their rising out-of-pocket costs for prescription medications since its launch in January 2007. “We are very pleased by the large number of patients who have come to OPTIMIZERx and discovered... - November 18, 2007 - OptimizeRx
New Internet Solution Enables Pharmaceutical Manufacturers to Improve Access, Adherence and Brand Loyalty
A new Internet service called OPTIMIZERx (www.optimizerx.com) will now allow pharmaceutical manufacturers to help patients better afford and comply with their prescribed brand medications. The pharmaceutical industry has come under increased pressure for the high cost of prescription medications, and major efforts are being made to steer patients towards the use of generic prescription medications. - November 18, 2007 - OptimizeRx
New Internet Site Helps Patients with Rising Prescription Drug Costs
A free, new Internet site called OPTIMIZERx (www.optimizerx.com) is now available to help the majority of patients reduce their rising costs for prescription medications. With escalating costs now being passed on to patients, many Americans are finding out the hard way that even with healthcare insurance, they are not immune to the rising cost of prescription medication. - November 15, 2007 - OptimizeRx
Octagon Announces ViewPoint(R) for Document Management
Octagon Research Solutions, Inc. announces ViewPoint(R) for document management. New solution supports the entire document lifecycle from authoring to submission. - November 14, 2007 - Octagon Research Solutions, Inc
Robert Copeland, VP, Oncology Drug Discovery, GSK to Give Keynote Talk at Cancer Drugs Conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug... - November 11, 2007 - GTCbio
Pfizer, Novartis, and AstraZeneca to Give Featured Presentations at Oncology Biomarkers Conference
Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. - November 11, 2007 - GTCbio
Octagon Research Solutions, Inc., Inducted in the Philadelphia 100 Hall of Fame
Octagon Research Solutions, Inc. and its Chairman and CEO, James C. Walker and Octagon Research Solutions, Inc. have been inducted in the Philadelphia 100 Hall of Fame. - November 03, 2007 - Octagon Research Solutions, Inc
Octagon Research Solutions, Inc. Ranked as One of the Fastest Growing Companies in North America on Deloitte’s 2007 Technology Fast 500
Octagon ranked number 424 on Deloitte’s 2007 Technology Fast 500. - November 02, 2007 - Octagon Research Solutions, Inc
Octagon Research Solutions, Inc. Ranked 19 in Deloitte's 2007 Greater Philadelphia Technology Fast 50
CEO and Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, today announced that it ranked Number 19 on Deloitte’s 2007 Greater Philadelphia Technology Fast 50. The Technology Fast 50... - November 01, 2007 - Octagon Research Solutions, Inc
NCSRT Introduces WORKS™, an Integrated Program of Products, Applications Guides, Optimization Tools, and Services
NCSRT Introduces WORKS™, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow™ TFF modules and industry leading PUROSEP®... - October 30, 2007 - NCSRT, Inc.
Gary Peltz, Head of Genetics & Genomics at Roche Palo Alto to Give Keynote Talk on Computational Genetics at PK/PD Track of 3rd Modern Drug Discovery & Development Summit
Gary Peltz, Head of Genetic/Genomics at Roche to give keynote presentation at PK/PD track at 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 26, 2007 - GTCbio
Taneaba Samuel, a Pharmacy Technician, Has Been Selected for Inclusion in the 2007-2008 Princeton Premier Registry
Taneaba Samuel, a pharmacy technician, has been selected for inclusion in the 2007-2008 Princeton Premier Registry. Taneaba is currently employed by the Mental Health and Mental Retardation Authority of Harris County in Sugar Land Texas. As a pharmacy technician, Taneaba helps the elderly as well... - October 21, 2007 - Princeton Premier
Dr. David Kaslow, Vice President of Infectious Diseases and Vaccines at Merck to Give Keynote Presentation at 3rd Modern Drug Discovery & Development Summit
Dr. David Kaslow, VP of Infectious Diseases and Vaccines at Merck will give the Keynote presentation at GTCbio’s Biological Therapeutics conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport. - October 19, 2007 - GTCbio
Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals Will Give the Keynote Presentation at 3rd Modern Drug Discovery & Development Summit
Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at GTCbio’s Drug Design & Lead Discovery conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 19, 2007 - GTCbio
AdvantaPure’s Reinforced Silicone Hose Now Offered in Custom Colors for At-a-Glance Identification
Multi-layer silicone hose, called APSM, from AdvantaPure is now available in custom colors for easy recognition. Colored APSM makes line identification quicker, as it eliminates the need to read a label. It also allows for recognition anywhere along the entire length of hose, a great advantage in situations where time is critical. Previously available only in white, the hose is used in pressure applications in the pharmaceutical, bioprocess, biomedical, chemical, food, and beverage industries. - October 17, 2007 - NewAge Industries, Inc.
Metabolic Disease Has a Greater Effect on the Health of Our Society Than Cancer
The 3rd World Summit on Metabolic Diseases explores the latest findings and treatments for Metabolic Diseases - October 15, 2007 - GTCbio
GTCbio’s 5th International Conference on Vaccines: All Things Considered
GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C. - October 15, 2007 - GTCbio
INVEGA™ Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL® in Acutely Ill Hospitalized Patients
In a comparison study between schizophrenia treatments INVEGA™ (paliperidone) Extended-Release Tablets and SEROQUEL® (quetiapine), Invega patients saw schizophrenia symptom improvements as early as five days into therapy and continued through the end of the two-week study period. Results were presented today at the 20th Annual U.S. Psychiatric and Mental Health Congress in Orlando, Florida. - October 13, 2007 - Johnson & Johnson
ExL to use Pulse Media’s Text Messaging Services at Upcoming Digital Pharma Conference
Exl Pharma and Pulse Media announce the use of Pulse Media's text messaging and mobile marketing services at ExL's upcoming conference, Digital Pharma - October 13, 2007 - Pulse Media Response
Neil Bodick, COO of Chorus – Eli Lilly & Co. to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
COO of Chorus, Eli Lilly & Co. announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 13, 2007 - GTCbio
Dr. William Heyward on the Forefront of the Fight Against the World's Deadliest Communicable Diseases
For nearly three decades, William Heyward has been on the forefront in the fight against some of the world's deadliest communicable diseases. HIV/AIDS, Ebola, haemophilius influenzae, hepatitis B, and hepatic cancer are among the many illnesses he has focused his attention on in places as far-flung as Zaire, Alaska, South America and Thailand. Dr. Heyward has lived on the leading edge of research on the causes, effects and prevention of devastating diseases among some of the world's poorest area - October 12, 2007 - William Heyward
GTCbio’s 3rd Modern Drug Discovery and Development Summit
GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston. - October 11, 2007 - GTCbio
Global Search for a Cancer Cure Drives Market for Benda Pharmaceutical’s Gene Therapy Medicine
China-AsiaStocks.com Profiles New Showcase China Stock for Investors Following Sector; Benda Pharmaceutical, Inc., Producer of Conventional and Traditional Chinese Medicines - October 11, 2007 - InvestorIdeas.com
SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 10, 2007 - GTCbio
Pharmaceutical Problem Solved with Conveyor Belt Technology
Smart conveyors assist pharmaceutical company control throughput of secure products. - October 08, 2007 - Automation Supplies
20 Year Sales Veteran Named ForceLogix Vice President of Sales to Drive Sales Performance Management and Sales Coaching Solutions
ForceLogix today announced the addition of Tim Hackett as its new Vice President of Worldwide Sales, with a focus to drive industry leading sales performance management and sales coaching to the marketplace. - October 03, 2007 - ForceLogix
World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board
Samaritan announced today the appointment of James E.K. Hildreth, M.D., a world renowned physician and HIV researcher, to its Scientific Advisory Board. The work of Dr. Hildreth in HIV/AIDS dates back to 1986 and focuses on blocking HIV infection by learning how HIV gets into cells. He has published more than 80 scientific articles and holds six patents. - October 03, 2007 - Samaritan Pharmaceuticals
Injectable Therapy Services, Inc. Receives JCAHO Gold Seal of Approval
Injectable Therapy Services, Inc (ITSRx Pharmacy) a leading national provider of specialty pharmaceuticals and affiliated healthcare services, announced that it has received the Gold Seal of Approval™ from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). - October 01, 2007 - Injectable Therapy Services Pharmacy
Hose Track(R) RFID System Outperforms Traditional Log Book Record Keeping for Process Components
AdvantaPure’s Hose Track identification system, designed for process components used in biopharmaceutical and other high-purity industries, offers several safety and security advantages over conventional pen-and-paper methods of recording component usage data. Hose Track uses RFID technology to monitor individual parts and their wear-related events such as cleaning cycles. It consolidates information into a database and eliminates problems like illegible handwriting and misfiled documents. - September 28, 2007 - NewAge Industries, Inc.
First Fully Dedicated Book to the Field Based Medical Science Liaison (MSL) Role Released
The first book solely dedicated to the field based Medical Science Liaison (MSL) is now available. Title of the book is: The Medical Science Liaison: An A to Z Guide - September 27, 2007 - Pharm, LLC
e-Healthcare Solutions, Inc. Enters Into Exclusive Representation Agreement with The American Academy of Family Physicians
e-Healthcare Solutions, Inc. and the American Academy of Family Physicians (AAFP) announced today an agreement calling for e-Healthcare Solutions to provide advertising exclusively to the award winning patient-focused health website familydoctor.org. e-Healthcare Solutions will centrally sell and... - September 19, 2007 - e-Healthcare Solutions, Inc.
DZS Announces New State of the Art Training Center
DZS Software Solutions, a leader in the clinical trials software industry, now provides a 10 student training center in Bound Brook, New Jersey. With comfort, style, convenience and professional, dynamic trainers, DZS software builds a solid foundation for comprehensive utilization of their... - September 14, 2007 - DZS Software Solutions
Russian and Indian CROs Announce Network Alliance for Expansion of Global Clinical Trials Services
On September 12, 2007 Synergy Research Group (SynRG), a Russia-based CRO with more than 5-years experience in clinical trials in Russia announced the establishment of a new CRO Worldwide Network alliance with Neeman Medical International (NMI), an India-based CRO. This is the second step made by... - September 14, 2007 - Synergy Research Group
Octagon Validates ViewPoint FUSE EDC Platform
Acquired Technology Meets Octagon’s High Standards - September 13, 2007 - Octagon Research Solutions, Inc
Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New Powerful Class of HIV Viral Drug
Dr. Roger Kenneth Hershline PhD MD, Chairman and Founder of CureHIV.us, agreed to provide samples of Global Humanceuticals, Inc’s NIAID#11039, a new powerful class of anti-HIV drug to clinical researchers. The drug is able de-activates the virus even if diluted nearly a billion times. - September 09, 2007 - CureHIV
Octagon Expands West Coast Presence
Company Opens Mountain View Office to Support EDC Operations - September 07, 2007 - Octagon Research Solutions, Inc
MAX Named Datalogic Quality Partner for Bar Code Scanner Solutions in Pharmaceutical, Lab and Warehouse Operations
MAX can offer customers exclusive access to Datalogic products, including latest bar code scanner products, development news and product demonstrations. - September 06, 2007 - Manufacturing Applications eXperts, Inc. (MAX)
MAX Freezer Tracking Solution and Janam XP Series Bar Code Scanners Improve Lab Operation Tracking
The MAX Freezer Tracking solution and Janam XP bar code scanners offer: Faster and improved data tracking; A unique upgrade featuring 1D and 2D scanning in one device; Bluetooth capability; Users of discontinued Symbol SPT 1800 scanner chance to upgrade and stay with latest Palm OS mobile compatibility. - September 06, 2007 - Manufacturing Applications eXperts, Inc. (MAX)
Octagon Research Solutions, Inc., Announced as Part of the Philadelphia 100® List of Fastest Growing Companies
Company honored for fifth consecutive year. - September 02, 2007 - Octagon Research Solutions, Inc
Octagon Research Solutions, Inc. Makes Inc. 5,000 List of Fastest-Growing Businesses
Octagon Ranks No. 1130 on the 2007 Inc. 5,000 with Three-Year Sales Growth of 318% - August 29, 2007 - Octagon Research Solutions, Inc
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve on Chemotherapy
Samaritan announced that it has entered into an exclusive licensing agreement with Georgetown University for a patent covering the Peripheral Benzodiazepine Receptor (PBR) which has led to Cancer drug candidates with the ability to inhibit cancerous tumors; and an imaging technique that could possibly distinguish cancerous tumors for a more targeted and improved chemotherapy. - August 21, 2007 - Samaritan Pharmaceuticals
Hypertension Training Company, a Disease Management Company, Announces the Launch of the "Hypertension Management Success Tracks" Program of Cost Effective HTN Management
Hypertension Training Company, a disease management company, specialized in training of Health Care Providers in cost effective management of Hypertension, announces the official launch of the program "Hypertension Success Tracks". "Hypertension Success Tracks" is designed to... - August 17, 2007 - Hypertension Training Company
USP Class Vi Approval Certifies Hose to an Increased Level of Purity for Sanitary Applications
AdvantaPure’s flexible rubber-covered hose has an FEP fluoropolymer core that has now been tested and approved for USP Class VI certification. The multi-ply hose, called APFRC, is well suited for both pressure and vacuum applications in a variety of clean process industries, such as pharmaceutical, food, distilled beverage, chemical, and biotech. The ingredients of APFRC’s smooth, non-stick FEP core also comply with FDA and USDA standards. - August 17, 2007 - NewAge Industries, Inc.
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
Samaritan Pharmaceuticals has exclusively licensed a patent application entitled "Structure Based Drug Design of Steroid Inhibitors" from Georgetown University. - August 16, 2007 - Samaritan Pharmaceuticals
Is Your Medical Science Liaison (MSL) Program Paying Enough to Attract and Retain the Best MSLs?
According to Medical Science Liaison Institute's independent surveys, more than half of medical science liaisons with less than 2 years of experience report earning a base salary of $100,000 to less than $125,000. - August 14, 2007 - Medical Science Liaison Institute
CoreRx™ Celebrates Its First Year of Operations
CoreRx™ celebrates its first year of operations 01 August2007. In their initial year of business CoreRx™ has serviced more than 25 clients, both domestic and abroad. The company has positioned themselves for successful growth strategies over the next few years. Included in... - August 03, 2007 - CoreRx, Inc.
Kirk Gallion of Octagon Research Solutions, Inc., Recognized by the PharmaVOICE 100
Octagon President honored as one of the most inspiring people in the life sciences industry - August 01, 2007 - Octagon Research Solutions, Inc